All Stories

  1. Early-Life Skin Microbial Biomarkers for Eczema Phenotypes in Chinese Toddlers
  2. Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives
  3. Interaction between Human Papillomavirus-Encoded E6 Protein and AurB Induces Cell Immortalization and Proliferation—A Potential Target of Intervention
  4. Public health impact of herpes zoster vaccination on older adults in Hong Kong
  5. E6-Encoded by Cancer-Causing Human Papillomavirus Interacts with Aurora Kinase A To Promote HPV-Mediated Carcinogenesis
  6. Preliminary Findings of the High Quantity of Microplastics in Faeces of Hong Kong Residents
  7. Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
  8. Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer
  9. Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
  10. Mucosal Antibody Response to SARS-CoV-2 in Paediatric and Adult Patients: A Longitudinal Study
  11. Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study
  12. Determinants and Interactions of Oral Bacterial and Fungal Microbiota in Healthy Chinese Adults
  13. Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
  14. Chimeric crRNA improves CRISPR–Cas12a specificity in the N501Y mutation detection of Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2
  15. Host inflammatory response is the major marker of severe respiratory syncytial virus infection in older adults
  16. Characterization of key amino acid substitutions and dynamics of the influenza virus H3N2 hemagglutinin
  17. COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
  18. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using in Silico Approach
  19. K-Mer Analyses Reveal Different Evolutionary Histories of Alpha, Beta, and Gamma Papillomaviruses
  20. Suppression of influenza virus infection by rhinovirus interference at the population, individual and cellular levels
  21. Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia
  22. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2
  23. Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities
  24. Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves
  25. Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections
  26. The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma
  27. Chemopreventive Role of Apigenin against the Synergistic Carcinogenesis of Human Papillomavirus and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
  28. SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric populations
  29. Stringent containment measures without complete city lockdown to achieve low incidence and mortality across two waves of COVID-19 in Hong Kong
  30. Epidemiological characteristics of the first 100 cases of coronavirus disease 2019 (COVID-19) in Hong Kong Special Administrative Region, China, a city with a stringent containment policy
  31. Persistence and clearance of oral human papillomavirus infections: a prospective population‐based cohort study
  32. Systematic review of human gut resistome studies revealed variable definitions and approaches
  33. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
  34. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
  35. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
  36. Review article: fungal alterations in inflammatory bowel diseases
  37. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
  38. Impact of Preservation Method and 16S rRNA Hypervariable Region on Gut Microbiota Profiling
  39. Role of polycyclic aromatic hydrocarbons as a co-factor in human papillomavirus-mediated carcinogenesis
  40. Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults
  41. Complete Genome Sequences of Six Novel Macaca mulatta Papillomavirus Types Isolated from Genital Sites of Rhesus Monkeys in Hong Kong SAR, China
  42. Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans
  43. Diversity of macaque microbiota compared to the human counterparts
  44. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection
  45. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes
  46. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong
  47. Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data
  48. Three decades of neonatal vaccination has greatly reduced antenatal prevalence of hepatitis B virus infection among gravidae covered by the program
  49. Age-specific seroprevalence of dengue infection in Hong Kong
  50. Prevalence and Epidemiologic Profile of Oral Infection with Alpha, Beta, and Gamma Papillomaviruses in an Asian Chinese Population
  51. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61)
  52. The role of adjuvant immunomodulatory agents for treatment of severe influenza
  53. Avian influenza A (H7N9) virus infections in humans across five epidemics in mainland China, 2013–2017
  54. Complete Genome Sequence of a Novel Human Papillomavirus Isolated from Oral Rinse
  55. Increased Detection of Emergent Recombinant Norovirus GII.P16-GII.2 Strains in Young Adults, Hong Kong, China, 2016–2017
  56. Clinical features and seasonality of parechovirus infection in an Asian subtropical city, Hong Kong
  57. First-In-Class Inhibitor of Ribosomal RNA Synthesis with Antimicrobial Activity against Staphylococcus aureus
  58. Ancient Evolution and Dispersion of Human Papillomavirus 58 Variants
  59. Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial
  60. Global Spread of Norovirus GII.17 Kawasaki 308, 2014–2016
  61. A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region
  62. Epidemiology and clinical analysis of critical patients with child maltreatment admitted to the intensive care units
  63. School-based surveillance for influenza vaccine effectiveness during 2014-2015 seasons in Hong Kong
  64. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
  65. Hepatitis B infection acquired after haematopioetic stem cell transplant through horizontal mode
  66. Complete Genome Sequence of an Emergent Recombinant GII.P16-GII.2 Norovirus Strain Associated with an Epidemic Spread in the Winter of 2016-2017 in Hong Kong, China
  67. IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza
  68. Exendin-4 Exhibits Enhanced Anti-tumor Effects in Diabetic Mice
  69. Molecular Epidemiology and Strain Comparison between Hepatitis E Viruses in Human Sera and Pig Livers during 2014 to 2016 in Hong Kong
  70. Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea
  71. Recurrent Infections of Emergent Norovirus GII.17 in an Elderly
  72. Increased Growth of a Newly Established Mouse Epithelial Cell Line Transformed with HPV-16 E7 in Diabetic Mice
  73. 10.1016/j.vaccine.2016.08.047
  74. Editorial
  75. Rotavirus vaccine effectiveness in Hong Kong children
  76. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections
  77. Ad Hoc Influenza Vaccination During Years of Significant Antigenic Drift in a Tropical City With 2 Seasonal Peaks
  78. Outcome of Encephalitis in Pediatric Intensive Care Unit
  79. Paramyxovirus Infection: Mortality and Morbidity in a Pediatric Intensive Care Unit
  80. Reduced Diagnostic Performance of Two Norovirus Antigen Enzyme Immunoassays for the Emergent Genogroup II Genotype 17 Kawasaki 2014 Variant
  81. Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences
  82. Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS
  83. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014
  84. Prevalence, Clinicopathological Characteristics, and Outcome of Human Papillomavirus-Associated Oropharyngeal Cancer in Southern Chinese Patients
  85. Complete Genome Sequence of a Novel Recombinant GII.Pe_GII.17 Norovirus Strain from Hong Kong in 2015
  86. The role of human papillomavirus in head and neck squamous cell carcinoma: A case control study on a southern Chinese population
  87. Hospitalization Incidence, Mortality, and Seasonality of Common Respiratory Viruses Over a Period of 15 Years in a Developed Subtropical City
  88. A home-school-doctor model to break the barriers for uptake of human papillomavirus vaccine
  89. Update in Viral Infections 2014
  90. Parental Attitudes and Factors Associated With Varicella Vaccination in Preschool and Schoolchildren in Hong Kong
  91. False-positive PCR detection of cyclovirus Malawi strain VS5700009 in human cerebrospinal fluid
  92. Virus Genotype Distribution and Virus Burden in Children and Adults Hospitalized for Norovirus Gastroenteritis, 2012–2014, Hong Kong
  93. High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections
  94. Prognostic Implication of Human Papillomavirus Types and Species in Cervical Cancer Patients Undergoing Primary Treatment
  95. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong – A decision analysis
  96. Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women
  97. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening
  98. influenza, respiratory syncytial virus, antivirals
  99. miR-466 is putative negative regulator of Coxsackie virus and Adenovirus Receptor
  100. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
  101. Burden of influenza infection in hospitalised children below 6 months of age and above in Hong Kong from 2005 to 2011
  102. Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide
  103. Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination
  104. Photodynamic inactivation of bacteria and viruses using two monosubstituted zinc(II) phthalocyanines
  105. Initial Radiographic Features as Outcome Predictor of Adult Respiratory Syncytial Virus Respiratory Tract Infection
  106. Typical or atypical pneumonia and severe acute respiratory symptoms in PICU
  107. Geographical Distribution and Risk Association of Human Papillomavirus Genotype 52–Variant Lineages
  108. Oligolysine-Conjugated Zinc(II) Phthalocyanines as Efficient Photosensitizers for Antimicrobial Photodynamic Therapy
  109. Global Genomic Diversity of Human Papillomavirus 6 Based on 724 Isolates and 190 Complete Genome Sequences
  110. Characteristics of Patients Infected with Norovirus GII.4 Sydney 2012, Hong Kong, China
  111. Characteristics of Patients Infected with Norovirus GII.4 Sydney 2012, Hong Kong, China
  112. Rotavirus incidence in hospitalised Hong Kong children: 1 July 1997 to 31 March 2011
  113. Recognizing true H5N1 infections in humans during confirmed outbreaks
  114. Selection of Referent Transcript for Normalization of Gene Expression in Cervical Cytology Samples
  115. Conformationally locked bicyclo[4.3.0]nonane carbanucleosides: synthesis and bio-evaluation
  116. Bench to Bed Evidences for Pharmacokinetic and Pharmacodynamic Interactions Involving Oseltamivir and Chinese Medicine
  117. Influenza Rapid Test
  118. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome
  119. Controlling novel avian influenza A (H7N9) at animal sources
  120. A Prospective Intervention Study on Higher-Dose Oseltamivir Treatment in Adults Hospitalized With Influenza A and B Infections
  121. Knowledge, Attitude, Practice and Barriers on Vaccination against Human Papillomavirus Infection: A Cross-Sectional Study among Primary Care Physicians in Hong Kong
  122. High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
  123. Rotavirus activity and meteorological variations in an Asian subtropical city, Hong Kong, 1995-2009
  124. Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population
  125. Enterovirus infection among patients admitted to hospital in Hong Kong in 2010: Epidemiology, clinical characteristics, and importance of molecular diagnosis
  126. A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18–26 years
  127. Replication and Transcription Activities of Ribonucleoprotein Complexes Reconstituted from Avian H5N1, H1N1pdm09 and H3N2 Influenza A Viruses
  128. Increased nasopharyngeal carriage of serotypes 6A, 6C, and 6D Streptococcus pneumoniae after introduction of childhood pneumococcal vaccination in Hong Kong
  129. Adjunctive therapies and immunomodulatory agents in the management of severe influenza
  130. Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes
  131. Indirect Immunofluorescence Assay for the Simultaneous Detection of Antibodies against Clinically Important Old and New World Hantaviruses
  132. Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial
  133. Role of human Toll-like receptors in naturally occurring influenza A infections
  134. A “pre-seasonal” hospital outbreak of influenza pneumonia caused by the drift variant A/Victoria/361/2011-like H3N2 viruses, Hong Kong, 2011
  135. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
  136. Role of Atypical Pathogens in Nursing Home–Acquired Pneumonia
  137. Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells
  138. Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses
  139. Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009
  140. Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong
  141. Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong
  142. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations
  143. Influenza B Lineage Circulation and Hospitalization Rates in a Subtropical City, Hong Kong, 2000-2010
  144. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis
  145. Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1
  146. Laboratory and clinical aspects of human papillomavirus testing
  147. Intact Survival of Refractory CMV Limbic Encephalitis in a Patient With Severe Aplastic Anemia After Unrelated Bone Marrow Transplantation
  148. Intestinal binding of seasonal influenza A viruses to DC-SIGN+CD68+cells
  149. Chronic psychosocial stress: does it modulate immunity to the influenza vaccine in Hong Kong Chinese elderly caregivers?
  150. Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department
  151. Comparisons of oseltamivir-resistant (H275Y) and concurrent oseltamivir-susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008-2009
  152. Differences in the compliance with hospital infection control practices during the 2009 influenza H1N1 pandemic in three countries
  153. Influenza Polymerase Activity Correlates with the Strength of Interaction between Nucleoprotein and PB2 through the Host-Specific Residue K/E627
  154. Structural Basis for RNA Binding and Homo-Oligomer Formation by Influenza B Virus Nucleoprotein
  155. H5N1 Avian Influenza in Children
  156. Human papillomavirus type 58: the unique role in cervical cancers in East Asia
  157. Inaccurate identification of rotavirus genotype G9 as genotype G3 strains due to primer mismatch
  158. Antagonist-mediated down-regulation of toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus
  159. Familial aggregation of narcolepsy
  160. Seasonal Influenza A Virus in Feces of Hospitalized Adults
  161. Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults
  162. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China
  163. Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries
  164. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: Comparison with self-reported history
  165. A Possible Geographic Origin of Endemic Hepatitis C Virus 6a in Hong Kong: Evidences for the Association with Vietnamese Immigration
  166. Clinical Spectrum of Human Rhinovirus Infections in Hospitalized Hong Kong Children
  167. Strengthening Observational Evidence for Antiviral Effectiveness in Influenza A (H5N1)
  168. Prevalence of human papillomavirus, Epstein-Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong patients
  169. Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?
  170. Identification of Human Papillomavirus Type 58 Lineages and the Distribution Worldwide
  171. Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: Susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment
  172. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer
  173. Pandemic (H1N1) 2009 vaccine in paediatric oncology patients: one dose or two doses?
  174. Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus
  175. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin
  176. Co-dominance of G1 and emerging G3 rotaviruses in Hong Kong: A three-year surveillance in three major hospitals
  177. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma
  178. Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: A prospective cohort study
  179. Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes
  180. Polymerase activity of hybrid ribonucleoprotein complexes generated from reassortment between 2009 pandemic H1N1 and seasonal H3N2 influenza A viruses
  181. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia
  182. Mutations around interferon sensitivity-determining region: A pilot resistance report of hepatitis C virus 1b in a Hong Kong population
  183. Possible Role of Aerosol Transmission in a Hospital Outbreak of Influenza
  184. Willingness to accept H1N1 pandemic influenza vaccine: A cross-sectional study of Hong Kong community nurses
  185. Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry
  186. Sequence diversity of hepatitis C virus 6a within the extended interferon sensitivity-determining region correlates with interferon-alpha/ribavirin treatment outcomes
  187. Influenza and Parainfluenza Associated Pediatric ICU Morbidity
  188. Severe Acute Respiratory Syndrome and Coronavirus
  189. An unusual cluster of HIV-1 B/F recombinants in an Asian population
  190. Prevalence and genotype distribution of cervical human papillomavirus infection in Macao
  191. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients
  192. T-Cell Response to Human Papillomavirus Type 58 L1, E6, and E7 Peptides in Women with Cleared Infection, Cervical Intraepithelial Neoplasia, or Invasive Cancer
  193. Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao
  194. Monitoring of perceptions, anticipated behavioral, and psychological responses related to H5N1 influenza
  195. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses
  196. Outcomes of adults hospitalised with severe influenza
  197. Functional Analysis of the Influenza Virus H5N1 Nucleoprotein Tail Loop Reveals Amino Acids That Are Crucial for Oligomerization and Ribonucleoprotein Activities
  198. HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: A role for ganciclovir prophylaxis?
  199. Co-infection With Pandemic H1N1 and Seasonal H3N2 Influenza Viruses
  200. Survey for the presence of BK, JC, KI, WU and Merkel cell polyomaviruses in human brain tissues
  201. CFTR is required for cellular entry and internalization ofChlamydia trachomatis
  202. RECOVERY OF HUMORAL AND CELLULAR IMMUNITIES TO VACCINE-PREVENTABLE INFECTIOUS DISEASES IN PEDIATRIC ONCOLOGY PATIENTS
  203. Clinical Management of Pandemic 2009 Influenza A(H1N1) Infection
  204. Narcissus tazetta lectin shows strong inhibitory effects against respiratory syncytial virus, influenza A (H1N1, H3N2, H5N1) and B viruses
  205. Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus
  206. Multiplex Molecular Detection of Respiratory Pathogens in Children With Asthma Exacerbation
  207. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies
  208. Profiles of cytokine and chemokine gene expression in human pulmonary epithelial cells induced by human and avian influenza viruses
  209. Two Antifungal Components Isolated from Fructus Psoraleae and Folium Eucalypti Globuli by Bioassay-Guided Purification
  210. Acute Encephalopathy Associated with Influenza A Infection in Adults
  211. Full Genome Analysis of an Emerging Cluster of Human Immunodeficiency Virus Type 1 Subtype B Infection in Hong Kong
  212. Acute Encephalopathy Associated with Influenza A Infection in Adults
  213. Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
  214. Natural History of Cervical Papilloma Virus Infection in Systemic Lupus Erythematosus -- A Prospective Cohort Study
  215. Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiology
  216. Prevalence of diarrhea viruses in hospitalized children in Hong Kong in 2008
  217. Role of ‘atypical pathogens’ among adult hospitalized patients with community‐acquired pneumonia
  218. Distribution of human papillomavirus types in cervical cancers in Hong Kong: Current situation and changes over the last decades
  219. Seasonal influenza activity in Hong Kong and its association with meteorological variations
  220. Distribution of Human Papillomavirus Type 58 Variants in Progression of Cervical Dysplasia in Korean Women
  221. Epidemiology and Clinical Presentations of Human Coronavirus NL63 Infections in Hong Kong Children
  222. Epidemiologic risk profile of infection with different groups of human papillomaviruses
  223. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys
  224. Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza
  225. Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms
  226. Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses
  227. Genotype Distribution and Sequence Variation of Hepatitis E Virus, Hong Kong
  228. Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong
  229. Distribution of human papillomavirus types in anogenital warts of men
  230. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients
  231. Acceptance of human papillomavirus vaccination among first year female university students in Hong Kong
  232. Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
  233. A wide spectrum of dengue IgM and PCR positivity post-onset of illness found in a large dengue 3 outbreak in Pakistan
  234. Analysis of Human Papillomavirus Type 18 Load and Integration Status from Low-Grade Cervical Lesion to Invasive Cervical Cancer
  235. Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin
  236. Identification of viral and atypical bacterial pathogens in children hospitalized with acute respiratory infections in Hong Kong by multiplex PCR assays
  237. Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection
  238. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans
  239. Involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in the pathogenesis of hydrosalpinx induced by Chlamydia trachomatis infection
  240. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
  241. Induction of cell cycle arrest and apoptosis by 5-fluorouracil in laryngeal cancer cells containing HPV16 E6 and E7 oncoproteins
  242. Genotypic analysis of two hypervariable human cytomegalovirus genes
  243. Failure to confirm HIV infection in two end-stage HIV/AIDS patients using a popular commercial line immunoassay
  244. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia
  245. Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?
  246. Influenza-like illness in residential care homes: a study of the incidence, aetiological agents, natural history and health resource utilisation
  247. Seasonality of Influenza A(H3N2) Virus: A Hong Kong Perspective (1997–2006)
  248. Comparative Study of Nasopharyngeal Aspirate and Nasal Swab Specimens for Diagnosis of Acute Viral Respiratory Infection
  249. Involvement of cystic fibrosis transmembrane conductance regulator in infection-induced edema
  250. Clearance of dengue virus in the plasma-derived therapeutic proteins
  251. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design
  252. Clinical features, pathogenesis and immunobiology of severe acute respiratory syndrome
  253. Pediatric hospitalization of acute respiratory tract infections with Human Bocavirus in Hong Kong
  254. Antiviral Treatment for Patients Hospitalized with Severe Influenza Infection May Affect Clinical Outcomes
  255. Increase of Integration Events and Infection Loads of Human Papillomavirus Type 52 with Lesion Severity from Low-Grade Cervical Lesion to Invasive Cancer
  256. Avian Influenza Virus A/HK/483/97(H5N1) NS1 Protein Induces Apoptosis in Human Airway Epithelial Cells
  257. Thrombopoietin levels increased in patients with severe acute respiratory syndrome
  258. Development of Human Single-Chain Antibodies against SARS-Associated Coronavirus
  259. Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006
  260. Airflow and droplet spreading around oxygen masks: A simulation model for infection control research
  261. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong
  262. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma
  263. Herpes Labialis
  264. Activation of the JNK pathway promotes phosphorylation and degradation of BimEL--a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia
  265. High Prevalence of the CD14-159CC Genotype in Patients Infected with Severe Acute Respiratory Syndrome-Associated Coronavirus
  266. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections
  267. Cytokine Profile in Fatal Human Immunodeficiency Virus–Tuberculosis–Epstein-Barr Virus–Associated Hemophagocytic Syndrome
  268. Profile of Viral Load, Integration, and E2 Gene Disruption of HPV58 in Normal Cervix and Cervical Neoplasia
  269. Hypercytokinemia and Hyperactivation of Phospho-p38 Mitogen-Activated Protein Kinase in Severe Human Influenza A Virus Infection
  270. Rapid Multiplex Nested PCR for Detection of Respiratory Viruses
  271. Viral Etiology of Acute Exacerbations of COPD in Hong Kong
  272. Fecal Viral Concentration and Diarrhea in Norovirus Gastroenteritis
  273. HLA-DQB1 polymorphisms and risk for cervical cancer: A case-control study in a southern Chinese population
  274. Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection
  275. Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection
  276. Serotype Distribution and Antimicrobial Susceptibilities of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children Hospitalized for Acute Respiratory Illnesses in Hong Kong
  277. Longitudinally Tracking Fluoroquinolone Resistance and Its Determinants in Penicillin-Susceptible and -Nonsusceptible Streptococcus pneumoniae Isolates in Hong Kong, 2000 to 2005
  278. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong
  279. Features discriminating SARS from other severe viral respiratory tract infections
  280. Streptococcus suis in Hong Kong
  281. Characterizing 56 complete SARS-CoV S-gene sequences from Hong Kong
  282. Genetic evolution of enterovirus 71: epidemiological and pathological implications
  283. Association Between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese
  284. A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD
  285. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection
  286. Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues
  287. Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy
  288. Viral Load, E2 Gene Disruption Status, and Lineage of Human Papillomavirus Type 16 Infection in Cervical Neoplasia
  289. Use of the housekeeping genes, gdh (zwf) and gki, in multilocus sequence typing to differentiate Streptococcus pneumoniae from Streptococcus mitis and Streptococcus oralis
  290. Antiviral property and mechanisms of a sulphated polysaccharide from the brown alga Sargassum patens against Herpes simplex virus type 1
  291. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises
  292. Extremely Low Exposure of a Community to Severe Acute Respiratory Syndrome Coronavirus: False Seropositivity due to Use of Bacterially Derived Antigens
  293. The Large 386‐nt Deletion in SARS‐Associated Coronavirus: Evidence for Quasispecies?
  294. Probable Intrafamilial Transmission of Coxsackievirus B3 With Vertical Transmission, Severe Early-Onset Neonatal Hepatitis, and Prolonged Viral RNA Shedding
  295. Airflows Around Oxygen Masks
  296. Fecal Viral Load and Norovirus-associated Gastroenteritis
  297. The detection of human herpesvirus-8 DNA in plasma and peripheral blood mononuclear cells in adult patients with pityriasis rosea by polymerase chain reaction
  298. Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)
  299. Sapovirus detection by quantitative real-time RT-PCR in clinical stool specimens
  300. Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy
  301. Anti–Severe Acute Respiratory Syndrome Coronavirus Immune Responses: The Role Played by Vγ9Vδ2 T Cells
  302. Rapid control of norovirus gastroenteritis outbreak in an acute paediatric ward
  303. Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients
  304. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
  305. SARS: clinical presentation, transmission, pathogenesis and treatment options
  306. Chikungunya Fever, Hong Kong
  307. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong
  308. Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
  309. Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome
  310. Risk Association between Human Leukocyte Antigen–A Allele and High‐Risk Human Papillomavirus Infection for Cervical Neoplasia in Chinese Women
  311. In vivo functional characterization of the SARS-Coronavirus 3a protein in Drosophila
  312. Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers
  313. A simple and rapid approach for screening of SARS-coronavirus genotypes: an evaluation study
  314. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women
  315. Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome
  316. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
  317. Human Parainfluenza Virus 4 Outbreak and the Role of Diagnostic Tests
  318. Estimates of Rotavirus Disease Burden in Hong Kong: Hospital‐Based Surveillance
  319. Hospital‐Based Study of the Economic Burden Associated with Rotavirus Diarrhea in Hong Kong
  320. Prevention of Hepatitis B Virus Reactivation in Patients With Nasopharyngeal Carcinoma With Lamivudine
  321. Antibody Avidity Maturation during Severe Acute Respiratory Syndrome–Associated Coronavirus Infection
  322. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma
  323. Transmission of hepatitis B by human bite—Confirmation by detection of virus in saliva and full genome sequencing
  324. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells
  325. Serum neopterin for early assessment of severity of severe acute respiratory syndrome
  326. Pityriasis rosea in pregnancy - specific diagnostic implications and management considerations
  327. Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS)
  328. Precautions in ophthalmic practice in a hospital with a major acute SARS outbreak: an experience from Hong Kong
  329. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study
  330. ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome
  331. Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
  332. Clinical significance of hepatic derangement in severe acute respiratory syndrome
  333. Tracing SARS-Coronavirus Variant with Large Genomic Deletion
  334. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
  335. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
  336. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: Association with human papillomavirus infection
  337. Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody
  338. ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome
  339. Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2
  340. Hematological findings in SARS patients and possible mechanisms (Review)
  341. Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid
  342. Tears and conjunctival scrapings for coronavirus in patients with SARS
  343. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
  344. Seroprevalence of Antibody to Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus among Health Care Workers in SARS and Non-SARS Medical Wards
  345. Diagnostic Criteria during SARS Outbreak in Hong Kong
  346. Synthetic Peptide Studies on the Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Glycoprotein: Perspective for SARS Vaccine Development
  347. Asymmetric periflexural exanthem in an adult
  348. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers
  349. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak
  350. The Spectrum of Severe Acute Respiratory Syndrome–Associated Coronavirus Infection
  351. Retrospective analysis of liver function derangement in severe acute respiratory syndrome
  352. Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome
  353. Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China
  354. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
  355. Immunofluorescence Assay for Serologic Diagnosis of SARS
  356. Human Metapneumovirus-associated Atypical Pneumonia and SARS
  357. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression
  358. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)
  359. Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy
  360. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients
  361. Cluster of SARS among Medical Students Exposed to Single Patient, Hong Kong
  362. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases
  363. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong
  364. Evaluation of a recombinant nucleocapsid protein-based assay for Anti-SARS-CoV IgG detection
  365. Persistent infection of SARS coronavirus in colonic cells in vitro
  366. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus
  367. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy
  368. Detection of SARS Coronavirus in Plasma by Real-Time RT-PCR
  369. A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification
  370. Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome
  371. Severe Acute Respiratory Syndrome–associated Coronavirus Infection
  372. Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong
  373. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection1 1The authors thank Man-yee Yung, Sara Fung, Dr. Bonnie Kwan, and Dr. Thomas Li for their help in retrieving patient information.
  374. Infants Born to Mothers With Severe Acute Respiratory Syndrome
  375. Genetic variation of glycoproteins B and H of human herpesvirus 7 in Hong Kong
  376. Human Metapneumovirus Detection in Patients with Severe Acute Respiratory Syndrome
  377. Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B
  378. A Hong Kong family with respiratory illness
  379. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
  380. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
  381. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
  382. A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
  383. Clinical presentations and outcome of severe acute respiratory syndrome in children
  384. Re: Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: A Nested Case-Control Study Among Men
  385. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers
  386. Isolation and characterization of a sulfated polysaccharide from the brown alga Sargassum patens and determination of its anti-herpes activity
  387. Human Papillomavirus Type 16 Intratypic Variant Infection and Risk for Cervical Neoplasia in Southern China
  388. Association of Human Papillomavirus Type 58 Variant With the Risk of Cervical Cancer
  389. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong
  390. Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children
  391. Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls
  392. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major
  393. Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997
  394. Case report: Human herpesvirus 7 associated fatal encephalitis in a peripheral blood stem cell transplant recipient
  395. Determinants of Cervical Human Papillomavirus Infection: Differences between High‐ and Low‐Oncogenic Risk Types
  396. Hepatitis B virus reactivation during cytotoxic chemotherapy‐enhanced viral replication precedes overt hepatitis
  397. Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein
  398. Prevalence and genotype distribution of TT virus in various specimen types from thalassaemic patients
  399. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA
  400. High Carriage Rate of TT Virus in the Cervices of Pregnant Women
  401. Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors
  402. Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain
  403. Clearance of TT Virus After Allogeneic Bone Marrow Transplantation
  404. Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy
  405. Rapid identification of medically important Candida to species level by polymerase chain reaction and single-strand conformational polymorphism
  406. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important role
  407. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation
  408. Risk of Influenza A (H5N1) Infection among Health Care Workers Exposed to Patients with Influenza A (H5N1), Hong Kong
  409. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
  410. Presence of human herpesviruses 6, 7, and 8 DNA sequences in normal brain tissue
  411. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus
  412. Detection of Human Herpesvirus 8 in Cervical Cells of Chinese Women with Abnormal Papanicolaou Smears
  413. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
  414. Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: seasonality and disease impact
  415. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions
  416. Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours
  417. Rubella immune status among healthcare workers in the Department of Obstetrics and Gynaecology of a regional hospital in Hong Kong: the need for a vaccination policy
  418. Rotavirus infection in Hong Kong: epidemiology and estimates of disease burden
  419. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
  420. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients
  421. Congenital infection by human cytomegalovirus with a 65 bp deletion in the morphological transforming region II